Free Trial

B. Riley Analysts Boost Earnings Estimates for Core Scientific, Inc. (NASDAQ:CORZ)

Core Scientific logo with Finance background

Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Equities researchers at B. Riley raised their FY2026 EPS estimates for shares of Core Scientific in a research note issued to investors on Friday, October 11th. B. Riley analyst L. Pipes now forecasts that the company will earn $0.22 per share for the year, up from their previous forecast of $0.19. B. Riley currently has a "Buy" rating and a $14.00 target price on the stock. The consensus estimate for Core Scientific's current full-year earnings is $0.01 per share.

A number of other analysts have also recently commented on CORZ. Sanford C. Bernstein reiterated an "outperform" rating and issued a $17.00 target price on shares of Core Scientific in a research note on Tuesday, September 10th. Macquarie assumed coverage on shares of Core Scientific in a research report on Wednesday, September 25th. They issued an "outperform" rating and a $16.00 target price on the stock. Canaccord Genuity Group assumed coverage on Core Scientific in a report on Monday, September 23rd. They set a "buy" rating and a $16.00 target price on the stock. HC Wainwright raised their price objective on Core Scientific from $11.00 to $15.00 and gave the stock a "buy" rating in a research report on Wednesday, July 10th. Finally, LADENBURG THALM/SH SH restated a "buy" rating and issued a $14.50 price objective on shares of Core Scientific in a report on Tuesday, July 2nd. Eleven analysts have rated the stock with a buy rating, According to MarketBeat, Core Scientific presently has an average rating of "Buy" and an average price target of $15.27.

View Our Latest Research Report on Core Scientific

Core Scientific Stock Down 1.9 %

NASDAQ:CORZ traded down $0.25 during mid-day trading on Monday, reaching $12.97. The company's stock had a trading volume of 12,893,676 shares, compared to its average volume of 8,581,288. Core Scientific has a 1 year low of $2.61 and a 1 year high of $13.42. The stock has a fifty day moving average of $10.80 and a 200-day moving average of $8.00.

Core Scientific (NASDAQ:CORZ - Get Free Report) last posted its quarterly earnings data on Wednesday, August 7th. The company reported ($4.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by ($4.47). The business had revenue of $141.10 million for the quarter, compared to analyst estimates of $128.58 million. The company's revenue was up 11.2% on a year-over-year basis.

Insider Buying and Selling

In related news, insider Todd M. Duchene sold 11,582 shares of the company's stock in a transaction on Friday, August 16th. The shares were sold at an average price of $9.41, for a total value of $108,986.62. Following the completion of the sale, the insider now directly owns 1,686,474 shares in the company, valued at approximately $15,869,720.34. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In related news, insider Todd M. Duchene sold 11,582 shares of the stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $9.41, for a total value of $108,986.62. Following the completion of the sale, the insider now owns 1,686,474 shares in the company, valued at approximately $15,869,720.34. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jarrod M. Patten acquired 4,000 shares of the stock in a transaction dated Wednesday, August 28th. The shares were purchased at an average price of $9.70 per share, for a total transaction of $38,800.00. Following the completion of the transaction, the director now owns 279,239 shares of the company's stock, valued at $2,708,618.30. This trade represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 12,761 shares of company stock worth $127,080. Insiders own 32.00% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of CORZ. Creative Planning lifted its position in shares of Core Scientific by 88.0% during the third quarter. Creative Planning now owns 32,925 shares of the company's stock worth $389,000 after purchasing an additional 15,413 shares in the last quarter. ORG Wealth Partners LLC bought a new position in Core Scientific in the 3rd quarter worth approximately $106,266,000. Rise Advisors LLC boosted its position in Core Scientific by 14.3% in the 3rd quarter. Rise Advisors LLC now owns 8,000 shares of the company's stock valued at $95,000 after buying an additional 1,000 shares during the last quarter. Shikiar Asset Management Inc. bought a new position in Core Scientific in the 3rd quarter valued at $889,000. Finally, LifePro Asset Management acquired a new stake in shares of Core Scientific in the 3rd quarter valued at $2,019,000.

Core Scientific Company Profile

(Get Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

Featured Stories

Earnings History and Estimates for Core Scientific (NASDAQ:CORZ)

Should you invest $1,000 in Core Scientific right now?

Before you consider Core Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.

While Core Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Broadcom’s Momentum Returns: Will It Reach New Highs?

Broadcom’s Momentum Returns: Will It Reach New Highs?

MarketBeat dives into Broadcom’s recent surge, impressive revenue growth, and why analysts believe there’s more upside ahead.

Related Videos

Why Congress Is Betting Big on Broadcom in 2024
Top 3 Stocks Members of Congress are Buying Ahead of the Election

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines